21-208
Are you post-menopausal, with ductal carcinoma in situ (DCIS) and expect to receive standard treatment for your DCIS? You may be eligible for a research study evaluate how immune systems (the part of your body that fights diseases) responds to an experimental treatment versus standard of care treatment. Compensation is provided.